• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源微小RNA-133a-3p、微小RNA-1-3p、高尔基磷蛋白3和连接蛋白联合使用可产生一种良好的生物标志物,用于区分前列腺癌患者和非前列腺癌患者。

Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients.

作者信息

Duca Rocío Belén, Massillo Cintia, Farré Paula Lucía, Graña Karen Daniela, Moro Juana, Gardner Kevin, Lacunza Ezequiel, De Siervi Adriana

机构信息

Laboratorio de Oncología Molecular y Nuevos Blancos Terapéuticos, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, United States.

出版信息

Front Oncol. 2022 Oct 26;12:997457. doi: 10.3389/fonc.2022.997457. eCollection 2022.

DOI:10.3389/fonc.2022.997457
PMID:36387263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9641240/
Abstract

The incidence and mortality of Prostate Cancer (PCa) worldwide correlate with age and bad dietary habits. Previously, we investigated the mRNA/miRNA role on PCa development and progression using high fat diet (HFD) fed mice. Here our main goal was to investigate the effect of HFD on the expression of PCa-related miRNAs and their relevance in PCa patients. We identified 6 up- and 18 down-regulated miRNAs in TRAMP-C1 mice prostate tumors under HFD conditions using miRNA microarrays. Three down-regulated miRNAs: mmu-miR-133a-3p, -1a-3p and -29c-3p were validated in TRAMP-C1 mice prostate tumor by stem-loop RT-qPCR. Hsa-miR-133a-3p/1-3p expression levels were significantly decreased in PCa compared to normal tissues while hsa-miR-133a-3p was found to be further decreased in metastatic prostate cancer tumors compared to non-metastatic PCa. We examined the promoter region of hsa-miR-133a-3p/1-3p genes and compared methylation at these loci with mature miRNA expression. We found that hsa-miR-1-2/miR-133a-1 cluster promoter hypermethylation decreased hsa-miR-133a-3p/1-3p expression in PCa. GOLPH3 and JUP, two hsa-miR-133a-3p and miR-1-3p predicted target genes, were up-regulated in PCa. ROC analysis showed that the combination of hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP is a promising panel biomarker to distinguish between PCa and normal adjacent tissue (NAT). These results link PCa aggressiveness to the attenuation of hsa-miR-133a-3p and miR-1-3p expression by promoter hypermethylation. Hsa-miR-133a-3p and miR-1-3p down-regulation may enhance PCa aggressiveness in part by targeting GOLPH3 and JUP.

摘要

全球前列腺癌(PCa)的发病率和死亡率与年龄及不良饮食习惯相关。此前,我们利用高脂饮食(HFD)喂养的小鼠研究了mRNA/miRNA在PCa发生发展中的作用。在此,我们的主要目标是研究HFD对PCa相关miRNA表达的影响及其在PCa患者中的相关性。我们使用miRNA芯片在HFD条件下的TRAMP-C1小鼠前列腺肿瘤中鉴定出6个上调和18个下调的miRNA。通过茎环RT-qPCR在TRAMP-C1小鼠前列腺肿瘤中验证了3个下调的miRNA:mmu-miR-133a-3p、-1a-3p和-29c-3p。与正常组织相比,PCa中hsa-miR-133a-3p/1-3p的表达水平显著降低,而与非转移性PCa相比,转移性前列腺癌肿瘤中hsa-miR-133a-3p进一步降低。我们检测了hsa-miR-133a-3p/1-3p基因的启动子区域,并将这些位点的甲基化与成熟miRNA的表达进行比较。我们发现hsa-miR-1-2/miR-133a-1簇启动子高甲基化降低了PCa中hsa-miR-133a-3p/1-3p的表达。GOLPH3和JUP是hsa-miR-133a-3p和miR-1-3p的两个预测靶基因,在PCa中上调。ROC分析表明,hsa-miR-133a-3p、miR-1-3p、GOLPH3和JUP的组合是区分PCa和正常相邻组织(NAT)的有前景的生物标志物组合。这些结果将PCa的侵袭性与启动子高甲基化导致的hsa-miR-133a-3p和miR-1-3p表达减弱联系起来。hsa-miR-133a-3p和miR-1-3p的下调可能部分通过靶向GOLPH3和JUP增强PCa的侵袭性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/f84b9d02ada4/fonc-12-997457-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/31e213afafd6/fonc-12-997457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/3326f6fcfb2a/fonc-12-997457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/1cafd8709da4/fonc-12-997457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/78582de66ce1/fonc-12-997457-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/9f8d87bd3086/fonc-12-997457-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/a33c35fb3eaa/fonc-12-997457-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/af90007082b2/fonc-12-997457-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/f84b9d02ada4/fonc-12-997457-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/31e213afafd6/fonc-12-997457-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/3326f6fcfb2a/fonc-12-997457-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/1cafd8709da4/fonc-12-997457-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/78582de66ce1/fonc-12-997457-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/9f8d87bd3086/fonc-12-997457-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/a33c35fb3eaa/fonc-12-997457-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/af90007082b2/fonc-12-997457-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a49/9641240/f84b9d02ada4/fonc-12-997457-g008.jpg

相似文献

1
Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients.人源微小RNA-133a-3p、微小RNA-1-3p、高尔基磷蛋白3和连接蛋白联合使用可产生一种良好的生物标志物,用于区分前列腺癌患者和非前列腺癌患者。
Front Oncol. 2022 Oct 26;12:997457. doi: 10.3389/fonc.2022.997457. eCollection 2022.
2
MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis.MiR-19b-3p和miR-101-3p作为前列腺癌诊断和预后的潜在生物标志物。
Am J Cancer Res. 2021 Jun 15;11(6):2802-2820. eCollection 2021.
3
Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.miR-133a-3p 的下调通过激活 PI3K/AKT 信号通路促进前列腺癌骨转移。
J Exp Clin Cancer Res. 2018 Jul 18;37(1):160. doi: 10.1186/s13046-018-0813-4.
4
Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development.代谢综合征小鼠的脂肪组织诱导与前列腺癌发展高度相关的异常 miRNA 特征。
Mol Oncol. 2020 Nov;14(11):2868-2883. doi: 10.1002/1878-0261.12788. Epub 2020 Sep 25.
5
microRNA Expression Profiling in Young Prostate Cancer Patients.年轻前列腺癌患者的微小RNA表达谱分析
J Cancer. 2020 Apr 7;11(14):4106-4114. doi: 10.7150/jca.37842. eCollection 2020.
6
Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.基于生物标志物优先级模型和致癌性调查的前列腺癌演变中关键 microRNA 及其机制的鉴定
Front Genet. 2021 Jan 15;11:596826. doi: 10.3389/fgene.2020.596826. eCollection 2020.
7
Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer.对微小RNA群体进行广泛筛选后发现,hsa-miR-375和hsa-miR-133a-3p是人类直肠癌和结肠癌的选择性标志物。
Oncotarget. 2018 Jun 5;9(43):27256-27267. doi: 10.18632/oncotarget.25535.
8
Droplet Digital PCR Analysis of Liquid Biopsy Samples Unveils the Diagnostic Role of hsa-miR-133a-3p and hsa-miR-375-3p in Oral Cancer.液体活检样本的微滴式数字PCR分析揭示了hsa-miR-133a-3p和hsa-miR-375-3p在口腔癌中的诊断作用。
Biology (Basel). 2020 Nov 6;9(11):379. doi: 10.3390/biology9110379.
9
Exosome-Derived miRNAs as Potential Biomarkers for Prostate Bone Metastasis.外泌体衍生的微小RNA作为前列腺骨转移的潜在生物标志物
Int J Gen Med. 2022 Jun 1;15:5369-5383. doi: 10.2147/IJGM.S361981. eCollection 2022.
10
Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population.开发和验证尿液 microRNA 生物标志物谱作为一种工具,用于在中国人群中早期检测前列腺癌。
Biomarkers. 2023 Jun;28(4):372-378. doi: 10.1080/1354750X.2023.2166587. Epub 2023 Apr 26.

引用本文的文献

1
Junction Plakoglobin - A Dual-Role Player in Cancer Biology.桥粒斑珠蛋白——癌症生物学中的双重角色参与者
Int J Surg. 2025 Jun 1;111(6):3920-3930. doi: 10.1097/JS9.0000000000002365. Epub 2025 Apr 1.
2
Exosomes loaded with the anti-cancer molecule mir-1-3p inhibit intrapulmonary colonization and growth of human esophageal squamous carcinoma cells.负载抗癌分子mir-1-3p的外泌体可抑制人食管鳞状癌细胞在肺内的定植和生长。
J Transl Med. 2024 Dec 31;22(1):1166. doi: 10.1186/s12967-024-05997-9.
3
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification.

本文引用的文献

1
MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis.MiR-19b-3p和miR-101-3p作为前列腺癌诊断和预后的潜在生物标志物。
Am J Cancer Res. 2021 Jun 15;11(6):2802-2820. eCollection 2021.
2
Opposing prognostic relevance of junction plakoglobin in distinct prostate cancer patient subsets.结斑蛋白在不同前列腺癌患者亚组中具有相反的预后相关性。
Mol Oncol. 2021 Jul;15(7):1956-1969. doi: 10.1002/1878-0261.12922. Epub 2021 Feb 17.
3
Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development.
前列腺癌临床与实验生物标志物的当代进展:一种聚焦多组学的检测与风险分层方法
Biology (Basel). 2024 Sep 25;13(10):762. doi: 10.3390/biology13100762.
4
LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p.长链非编码RNA LOC730101通过抑制miR-1-3p促进前列腺癌对达洛鲁胺的耐药性。
Cancers (Basel). 2024 Jul 20;16(14):2594. doi: 10.3390/cancers16142594.
5
The important role of miR-1-3p in cancers.miR-1-3p 在癌症中的重要作用。
J Transl Med. 2023 Oct 31;21(1):769. doi: 10.1186/s12967-023-04649-8.
代谢综合征小鼠的脂肪组织诱导与前列腺癌发展高度相关的异常 miRNA 特征。
Mol Oncol. 2020 Nov;14(11):2868-2883. doi: 10.1002/1878-0261.12788. Epub 2020 Sep 25.
4
Visualizing and interpreting cancer genomics data via the Xena platform.通过Xena平台可视化和解读癌症基因组学数据。
Nat Biotechnol. 2020 Jun;38(6):675-678. doi: 10.1038/s41587-020-0546-8.
5
Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression.关于高脂饮食诱导前列腺癌发生和进展的研究证据
J Clin Med. 2019 Apr 30;8(5):597. doi: 10.3390/jcm8050597.
6
CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.CTBP1 缺失会使前列腺肿瘤中的 miRNA/mRNA 表达失调,并损害代谢综合征小鼠中的肿瘤进展。
Cell Death Dis. 2019 Apr 1;10(4):299. doi: 10.1038/s41419-019-1535-z.
7
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer.大规模循环 microRNA 分析在前列腺癌液体活检中的应用。
Clin Cancer Res. 2019 May 15;25(10):3016-3025. doi: 10.1158/1078-0432.CCR-18-2849. Epub 2019 Feb 26.
8
Identification of a Novel MicroRNA Panel Associated with Metastasis Following Radical Prostatectomy for Prostate Cancer.前列腺癌根治术后与转移相关的新型微小RNA组合的鉴定
Anticancer Res. 2018 Sep;38(9):5027-5034. doi: 10.21873/anticanres.12821.
9
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.拟肿瘤抑制因子 miR-1-3p 通过抑制 E2F5 和 PFTK1 来调节前列腺癌细胞的侵袭性。
J Exp Clin Cancer Res. 2018 Sep 5;37(1):219. doi: 10.1186/s13046-018-0895-z.
10
CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome.CTBP1/CYP19A1/雌二醇轴与脂肪组织一起影响与代谢综合征相关的前列腺癌生长。
Int J Cancer. 2019 Mar 1;144(5):1115-1127. doi: 10.1002/ijc.31773. Epub 2018 Oct 9.